Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2003
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1363891A2 Anthrone derivatives and their use as jnk inhibitors
11/26/2003EP1363887A1 Substituted quinolinecarboxamides as antiviral agents
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
11/26/2003EP1363874A2 Tryptase inhibitors
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363704A2 Dapd combination therapy with inosine monophosphate dehydrogenase inhibitor
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1363677A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing
11/26/2003EP1363668A2 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
11/26/2003EP1363664A2 Synthetic vaccine agents
11/26/2003EP1363663A2 Nucleic acid mucosal immunization
11/26/2003EP1363657A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
11/26/2003EP1363653A2 Methods and compositions for enhancing angiogenesis
11/26/2003EP1363650A2 AQUATIC ANIMAL TREATMENT METHOD AND COMPOSITION CONTAINING i PIMENTA /i EXTRACT
11/26/2003EP1363648A1 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity
11/26/2003EP1363639A1 PYRROLO 2,3-d]PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
11/26/2003EP1363638A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/26/2003EP1363637A1 Pyrimidine compounds and methods for making and using the same
11/26/2003EP1363636A1 A method for the treatment of heart failure
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363630A2 Kappa opioid receptor ligands
11/26/2003EP1363629A1 Kappa opioid receptor ligands
11/26/2003EP1363628A2 Drugs for sex dysfunctions
11/26/2003EP1363624A2 Fluoro oxindole derivatives as modulators of kcnq potassium channels
11/26/2003EP1363623A2 Peptide deformylase inhibitors
11/26/2003EP1363622A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
11/26/2003EP1363620A2 Use of fredericamycin and its derivatives in the treatment of pin1-associated states
11/26/2003EP1363619A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
11/26/2003EP1363615A1 Preservation of body protein
11/26/2003EP1363614A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
11/26/2003EP1363606A1 Use of gaba[a] inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators or vitamin e for the treatment of coginitive disorders
11/26/2003EP1363605A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
11/26/2003EP1363602A1 Local anesthetic, and method of use
11/26/2003EP1363516A1 An improved process for preparing simvastatin
11/26/2003EP1363509A1 Compositions containing creatine and creatinine
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003EP1258490B1 Process for preparing indolopyrrolocarbazole derivatives, intermediates thereof, and preparation process of the intermediates
11/26/2003EP1204659B1 Serotonergic benzofurans
11/26/2003EP1000046B1 Piperazine derivatives active on the lower urinary tract
11/26/2003EP1000028B1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/26/2003EP0923546B1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
11/26/2003EP0912601B1 Suppression of immune response via inhibition of cathepsin s
11/26/2003EP0888123B1 Antagonism of endothelin actions
11/26/2003EP0765326B1 Benzoylecgonine, ecgonine and ecgonidine derivatives
11/26/2003EP0705278B1 Apoptose inhibitor
11/26/2003EP0605474B1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458974A Stimulation of cartilage growth with agonists of non-protecolytically activated thrombin receptor
11/26/2003CN1458933A Thienopyrimidine compounds and their salts and process for preparation of both
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458928A N-substituted benzothiophenesulfonamide derivatives
11/26/2003CN1458923A Substituted amino-aza-cycloalkanes useful against malaria
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458845A Pharmaceutical composition comprising condensed indole compound
11/26/2003CN1458844A Method of using diketopiperazines and composition containing them
11/26/2003CN1458842A 细胞活化剂 Cell activator
11/26/2003CN1458841A Use of matrix metalloprotease ihibitors for treatment of cancer
11/26/2003CN1458840A Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/26/2003CN1457874A Medicine for treating child chronic spenopathy and its preparing method
11/26/2003CN1457851A Chinese medicine formula with treating and health function
11/26/2003CN1457800A Formula of anti-senility tablet and preparing method
11/26/2003CN1457793A Use of ginsenoside in making medicine
11/26/2003CN1457789A Medicinal composition containing triphenyl-boroxin for boron neutron catching treatment
11/26/2003CN1128789C Benzocycloheptathiophene compounds
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/26/2003CN1128618C Use of histamine for elevating blood histamine
11/26/2003CN1128613C Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio- and post menopansal woman
11/26/2003CN1128586C Health-care reed beverage
11/25/2003US6653476 Thienopyridine derivatives, their production and use
11/25/2003US6653471 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653350 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
11/25/2003US6653348 Antiinflammatory agent for humans
11/25/2003US6653347 For therapy
11/25/2003US6653336 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
11/25/2003US6653325 Dyskinesias, by administering a substituted phenylazacycloalkane and a dopamine agonist to the patient
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/25/2003US6653322 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
11/25/2003US6653321 Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia
11/25/2003US6653315 Substituted 5-amino-imidazolo-(4,3-e)-1,2,4-triazolo(1,5-c)-pyrimidines; central nervous system diseases; Parkinson's disease
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653305 For therapy of tumoral diseases, diseases of the lungs and respiratory tract
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653290 Tumor proliferation inhibitors
11/25/2003US6653285 Polypeptide inhibitors and enhancers of glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparin, keratan sulfate, chitin and chitosans; antiinflammatory and anticarcinogenic agents; infections
11/25/2003US6653283 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/25/2003US6653278 Selenium-containing pro-drugs for cancer therapy
11/25/2003US6653134 Obtaining a bone marrow sample from a human, isolating stromal cells, and administering to the central nervous system of the patient; treating a genetic disease, a tumor, trauma and stroke
11/25/2003US6653133 Antisense modulation of Fas mediated signaling
11/25/2003US6653131 Method of treating systemic inflammatory response syndrome
1 ... 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 ... 1564